世界のジェネリック腫瘍薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Generic Oncology Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4251
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ジェネリック腫瘍薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（高分子薬、小分子薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ジェネリック腫瘍薬の市場動向
・企業の競争状況、市場シェア
・ジェネリック腫瘍薬の種類別市場規模と予測2016-2027（高分子薬、小分子薬）
・ジェネリック腫瘍薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局）
・ジェネリック腫瘍薬の北米市場規模2016-2027（アメリカ、カナダ）
・ジェネリック腫瘍薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ジェネリック腫瘍薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ジェネリック腫瘍薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・ジェネリック腫瘍薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、GlaxoSmithKline、Novartis、Merck、Celgene、Teva Pharmaceutical、Mylan、Aurobindo Pharma、Hikma Pharmaceuticals、Natco Pharma）
・結論

Market Analysis and Insights: Global Generic Oncology Drugs Market
The global Generic Oncology Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Generic Oncology Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Generic Oncology Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Generic Oncology Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Generic Oncology Drugs market.

Global Generic Oncology Drugs Scope and Market Size
Generic Oncology Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Generic Oncology Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Large Molecule Drugs
Small Molecule Drugs

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
GlaxoSmithKline
Novartis
Merck
Celgene
Teva Pharmaceutical
Mylan
Aurobindo Pharma
Hikma Pharmaceuticals
Natco Pharma

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Oncology Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Large Molecule Drugs
1.2.3 Small Molecule Drugs
1.3 Market by Application
1.3.1 Global Generic Oncology Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Generic Oncology Drugs Market Perspective (2016-2027)
2.2 Generic Oncology Drugs Growth Trends by Regions
2.2.1 Generic Oncology Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Generic Oncology Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Generic Oncology Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Generic Oncology Drugs Industry Dynamic
2.3.1 Generic Oncology Drugs Market Trends
2.3.2 Generic Oncology Drugs Market Drivers
2.3.3 Generic Oncology Drugs Market Challenges
2.3.4 Generic Oncology Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Generic Oncology Drugs Players by Revenue
3.1.1 Global Top Generic Oncology Drugs Players by Revenue (2016-2021)
3.1.2 Global Generic Oncology Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Generic Oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Generic Oncology Drugs Revenue
3.4 Global Generic Oncology Drugs Market Concentration Ratio
3.4.1 Global Generic Oncology Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Oncology Drugs Revenue in 2020
3.5 Generic Oncology Drugs Key Players Head office and Area Served
3.6 Key Players Generic Oncology Drugs Product Solution and Service
3.7 Date of Enter into Generic Oncology Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Generic Oncology Drugs Breakdown Data by Type
4.1 Global Generic Oncology Drugs Historic Market Size by Type (2016-2021)
4.2 Global Generic Oncology Drugs Forecasted Market Size by Type (2022-2027)

5 Generic Oncology Drugs Breakdown Data by Application
5.1 Global Generic Oncology Drugs Historic Market Size by Application (2016-2021)
5.2 Global Generic Oncology Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Generic Oncology Drugs Market Size (2016-2027)
6.2 North America Generic Oncology Drugs Market Size by Type
6.2.1 North America Generic Oncology Drugs Market Size by Type (2016-2021)
6.2.2 North America Generic Oncology Drugs Market Size by Type (2022-2027)
6.2.3 North America Generic Oncology Drugs Market Size by Type (2016-2027)
6.3 North America Generic Oncology Drugs Market Size by Application
6.3.1 North America Generic Oncology Drugs Market Size by Application (2016-2021)
6.3.2 North America Generic Oncology Drugs Market Size by Application (2022-2027)
6.3.3 North America Generic Oncology Drugs Market Size by Application (2016-2027)
6.4 North America Generic Oncology Drugs Market Size by Country
6.4.1 North America Generic Oncology Drugs Market Size by Country (2016-2021)
6.4.2 North America Generic Oncology Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Generic Oncology Drugs Market Size (2016-2027)
7.2 Europe Generic Oncology Drugs Market Size by Type
7.2.1 Europe Generic Oncology Drugs Market Size by Type (2016-2021)
7.2.2 Europe Generic Oncology Drugs Market Size by Type (2022-2027)
7.2.3 Europe Generic Oncology Drugs Market Size by Type (2016-2027)
7.3 Europe Generic Oncology Drugs Market Size by Application
7.3.1 Europe Generic Oncology Drugs Market Size by Application (2016-2021)
7.3.2 Europe Generic Oncology Drugs Market Size by Application (2022-2027)
7.3.3 Europe Generic Oncology Drugs Market Size by Application (2016-2027)
7.4 Europe Generic Oncology Drugs Market Size by Country
7.4.1 Europe Generic Oncology Drugs Market Size by Country (2016-2021)
7.4.2 Europe Generic Oncology Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Generic Oncology Drugs Market Size (2016-2027)
8.2 Asia-Pacific Generic Oncology Drugs Market Size by Type
8.2.1 Asia-Pacific Generic Oncology Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Generic Oncology Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Generic Oncology Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Generic Oncology Drugs Market Size by Application
8.3.1 Asia-Pacific Generic Oncology Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Generic Oncology Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Generic Oncology Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Generic Oncology Drugs Market Size by Region
8.4.1 Asia-Pacific Generic Oncology Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Generic Oncology Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Generic Oncology Drugs Market Size (2016-2027)
9.2 Latin America Generic Oncology Drugs Market Size by Type
9.2.1 Latin America Generic Oncology Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Generic Oncology Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Generic Oncology Drugs Market Size by Type (2016-2027)
9.3 Latin America Generic Oncology Drugs Market Size by Application
9.3.1 Latin America Generic Oncology Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Generic Oncology Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Generic Oncology Drugs Market Size by Application (2016-2027)
9.4 Latin America Generic Oncology Drugs Market Size by Country
9.4.1 Latin America Generic Oncology Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Generic Oncology Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Generic Oncology Drugs Market Size (2016-2027)
10.2 Middle East & Africa Generic Oncology Drugs Market Size by Type
10.2.1 Middle East & Africa Generic Oncology Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Generic Oncology Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Generic Oncology Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Generic Oncology Drugs Market Size by Application
10.3.1 Middle East & Africa Generic Oncology Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Generic Oncology Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Generic Oncology Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Generic Oncology Drugs Market Size by Country
10.4.1 Middle East & Africa Generic Oncology Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Generic Oncology Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Generic Oncology Drugs Introduction
11.1.4 Pfizer Revenue in Generic Oncology Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Generic Oncology Drugs Introduction
11.2.4 GlaxoSmithKline Revenue in Generic Oncology Drugs Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Generic Oncology Drugs Introduction
11.3.4 Novartis Revenue in Generic Oncology Drugs Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Generic Oncology Drugs Introduction
11.4.4 Merck Revenue in Generic Oncology Drugs Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Celgene Business Overview
11.5.3 Celgene Generic Oncology Drugs Introduction
11.5.4 Celgene Revenue in Generic Oncology Drugs Business (2016-2021)
11.5.5 Celgene Recent Development
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Details
11.6.2 Teva Pharmaceutical Business Overview
11.6.3 Teva Pharmaceutical Generic Oncology Drugs Introduction
11.6.4 Teva Pharmaceutical Revenue in Generic Oncology Drugs Business (2016-2021)
11.6.5 Teva Pharmaceutical Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Generic Oncology Drugs Introduction
11.7.4 Mylan Revenue in Generic Oncology Drugs Business (2016-2021)
11.7.5 Mylan Recent Development
11.8 Aurobindo Pharma
11.8.1 Aurobindo Pharma Company Details
11.8.2 Aurobindo Pharma Business Overview
11.8.3 Aurobindo Pharma Generic Oncology Drugs Introduction
11.8.4 Aurobindo Pharma Revenue in Generic Oncology Drugs Business (2016-2021)
11.8.5 Aurobindo Pharma Recent Development
11.9 Hikma Pharmaceuticals
11.9.1 Hikma Pharmaceuticals Company Details
11.9.2 Hikma Pharmaceuticals Business Overview
11.9.3 Hikma Pharmaceuticals Generic Oncology Drugs Introduction
11.9.4 Hikma Pharmaceuticals Revenue in Generic Oncology Drugs Business (2016-2021)
11.9.5 Hikma Pharmaceuticals Recent Development
11.10 Natco Pharma
11.10.1 Natco Pharma Company Details
11.10.2 Natco Pharma Business Overview
11.10.3 Natco Pharma Generic Oncology Drugs Introduction
11.10.4 Natco Pharma Revenue in Generic Oncology Drugs Business (2016-2021)
11.10.5 Natco Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Generic Oncology Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Large Molecule Drugs
Table 3. Key Players of Small Molecule Drugs
Table 4. Global Generic Oncology Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Generic Oncology Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Generic Oncology Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Generic Oncology Drugs Market Share by Regions (2016-2021)
Table 8. Global Generic Oncology Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Generic Oncology Drugs Market Share by Regions (2022-2027)
Table 10. Generic Oncology Drugs Market Trends
Table 11. Generic Oncology Drugs Market Drivers
Table 12. Generic Oncology Drugs Market Challenges
Table 13. Generic Oncology Drugs Market Restraints
Table 14. Global Generic Oncology Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Generic Oncology Drugs Market Share by Players (2016-2021)
Table 16. Global Top Generic Oncology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Oncology Drugs as of 2020)
Table 17. Ranking of Global Top Generic Oncology Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Generic Oncology Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Generic Oncology Drugs Product Solution and Service
Table 21. Date of Enter into Generic Oncology Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Generic Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Generic Oncology Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Generic Oncology Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Generic Oncology Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Generic Oncology Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Generic Oncology Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Generic Oncology Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Generic Oncology Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Generic Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Generic Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Generic Oncology Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Generic Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Generic Oncology Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Generic Oncology Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Generic Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Generic Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Generic Oncology Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Generic Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Generic Oncology Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Generic Oncology Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Generic Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Generic Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Generic Oncology Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Generic Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Generic Oncology Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Generic Oncology Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Generic Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Generic Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Generic Oncology Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Generic Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Generic Oncology Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Generic Oncology Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Generic Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Generic Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Generic Oncology Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Generic Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Generic Oncology Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Generic Oncology Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Generic Oncology Drugs Product
Table 64. Pfizer Revenue in Generic Oncology Drugs Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Generic Oncology Drugs Product
Table 69. GlaxoSmithKline Revenue in Generic Oncology Drugs Business (2016-2021) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Generic Oncology Drugs Product
Table 74. Novartis Revenue in Generic Oncology Drugs Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Generic Oncology Drugs Product
Table 79. Merck Revenue in Generic Oncology Drugs Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Celgene Company Details
Table 82. Celgene Business Overview
Table 83. Celgene Generic Oncology Drugs Product
Table 84. Celgene Revenue in Generic Oncology Drugs Business (2016-2021) & (US$ Million)
Table 85. Celgene Recent Development
Table 86. Teva Pharmaceutical Company Details
Table 87. Teva Pharmaceutical Business Overview
Table 88. Teva Pharmaceutical Generic Oncology Drugs Product
Table 89. Teva Pharmaceutical Revenue in Generic Oncology Drugs Business (2016-2021) & (US$ Million)
Table 90. Teva Pharmaceutical Recent Development
Table 91. Mylan Company Details
Table 92. Mylan Business Overview
Table 93. Mylan Generic Oncology Drugs Product
Table 94. Mylan Revenue in Generic Oncology Drugs Business (2016-2021) & (US$ Million)
Table 95. Mylan Recent Development
Table 96. Aurobindo Pharma Company Details
Table 97. Aurobindo Pharma Business Overview
Table 98. Aurobindo Pharma Revenue in Generic Oncology Drugs Business (2016-2021) & (US$ Million)
Table 99. Aurobindo Pharma Recent Development
Table 100. Hikma Pharmaceuticals Company Details
Table 101. Hikma Pharmaceuticals Business Overview
Table 102. Hikma Pharmaceuticals Generic Oncology Drugs Product
Table 103. Hikma Pharmaceuticals Revenue in Generic Oncology Drugs Business (2016-2021) & (US$ Million)
Table 104. Hikma Pharmaceuticals Recent Development
Table 105. Natco Pharma Company Details
Table 106. Natco Pharma Business Overview
Table 107. Natco Pharma Generic Oncology Drugs Product
Table 108. Natco Pharma Revenue in Generic Oncology Drugs Business (2016-2021) & (US$ Million)
Table 109. Natco Pharma Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Generic Oncology Drugs Market Share by Type: 2020 VS 2027
Figure 2. Large Molecule Drugs Features
Figure 3. Small Molecule Drugs Features
Figure 4. Global Generic Oncology Drugs Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Generic Oncology Drugs Report Years Considered
Figure 9. Global Generic Oncology Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Generic Oncology Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Generic Oncology Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Generic Oncology Drugs Market Share by Regions (2022-2027)
Figure 13. Global Generic Oncology Drugs Market Share by Players in 2020
Figure 14. Global Top Generic Oncology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Oncology Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Generic Oncology Drugs Revenue in 2020
Figure 16. Global Generic Oncology Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Generic Oncology Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Generic Oncology Drugs Market Share by Type (2016-2027)
Figure 20. North America Generic Oncology Drugs Market Share by Application (2016-2027)
Figure 21. North America Generic Oncology Drugs Market Share by Country (2016-2027)
Figure 22. United States Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Generic Oncology Drugs Market Share by Type (2016-2027)
Figure 26. Europe Generic Oncology Drugs Market Share by Application (2016-2027)
Figure 27. Europe Generic Oncology Drugs Market Share by Country (2016-2027)
Figure 28. Germany Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Generic Oncology Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Generic Oncology Drugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Generic Oncology Drugs Market Share by Region (2016-2027)
Figure 38. China Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Generic Oncology Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Generic Oncology Drugs Market Share by Application (2016-2027)
Figure 47. Latin America Generic Oncology Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Generic Oncology Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Generic Oncology Drugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Generic Oncology Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Generic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Generic Oncology Drugs Business (2016-2021)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Generic Oncology Drugs Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Generic Oncology Drugs Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Generic Oncology Drugs Business (2016-2021)
Figure 61. Celgene Revenue Growth Rate in Generic Oncology Drugs Business (2016-2021)
Figure 62. Teva Pharmaceutical Revenue Growth Rate in Generic Oncology Drugs Business (2016-2021)
Figure 63. Mylan Revenue Growth Rate in Generic Oncology Drugs Business (2016-2021)
Figure 64. Aurobindo Pharma Revenue Growth Rate in Generic Oncology Drugs Business (2016-2021)
Figure 65. Hikma Pharmaceuticals Revenue Growth Rate in Generic Oncology Drugs Business (2016-2021)
Figure 66. Natco Pharma Revenue Growth Rate in Generic Oncology Drugs Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の腫瘍小分子薬市場規模・現状・予測（2021年-2027年）

Global Oncology Small Molecule Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4607 2021年6月 126Pages
QYResearch社発行の本調査レポートでは、腫瘍小分子薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学治療薬、免疫調節薬、標的治療薬、ホルモン療法、その他）、用途別市場規模（血液がん、乳がん、消化器がん、前立腺がん、肺がん、その他）、主要...

世界の合成致死性基準薬剤＆標的市場規模・現状・予測（2021年-2027年）

Global Synthetic Lethality-based Drugs and Targets Market Size, Status and Forecast 2021-2027
QFJ1-5356 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、合成致死性基準薬剤＆標的の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（医療研究機関、病院・クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の免疫腫瘍学アッセイ市場規模・現状・予測（2021年-2027年）

Global Immuno Oncology Assays Market Size, Status and Forecast 2021-2027
QFJ1-4349 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、免疫腫瘍学アッセイの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イムノアッセイ、フローサイトメトリー、PCR、次世代シーケンシング）、用途別市場規模（研究所、臨床診断）、主要地域別市場規模（北米、ア...

一般医薬品のグローバル市場2021

Global Generic Drugs Sales Market Report 2021
QAF27699 2021年4月8日 143Pages
本市場調査資料では、世界の一般医薬品市場について種類別（シンプル一般医薬品、スーパー一般医薬品、バイオシミラー）、用途別（CNS、循環器、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍学、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2...

世界の腫瘍血液検査市場規模・現状・予測（2021年-2027年）

Global Oncology Blood Testing Market Size, Status and Forecast 2021-2027
QFJ1-4605 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、腫瘍血液検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、乳がん、結腸直腸がん、前立腺がん、胃がん、その）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、ア...

世界の内分泌癌治療薬市場規模・現状・予測（2021年-2027年）

Global Neuroendocrine Carcinoma Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5880 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、内分泌癌治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ソマトスタチン類似体、標的療法薬、化学療法薬）、用途別市場規模（病院、クリニック、オンコロジーセンター、外来手術センター）、主要地域別市場...

世界のVEGF阻害薬市場規模・現状・予測（2021年-2027年）

Global VEGF Inhibitor Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6064 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、VEGF阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（チロシンキナーゼ阻害剤、モノクローナル抗体、その他）、用途別市場規模（腫瘍内科、眼科、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の腫瘍バイオマーカー市場規模・現状・予測（2021年-2027年）

Global Oncology Biomarker Market Size, Status and Forecast 2021-2027
QFJ1-4604 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、腫瘍バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液がん、固形腫瘍、その他）、用途別市場規模（診断、創薬・開発、予後、リスクアセスメント、その他）、主要地域別市場規模（北米、アメリカ...

世界の動物腫瘍市場規模・現状・予測（2021年-2027年）

Global Veterinary Oncology Market Size, Status and Forecast 2021-2027
QFJ1-5020 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、動物腫瘍の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術、放射線、化学療法、免疫療法、その他（併用療法、分子標的療法））、用途別市場規模（イヌ科、ネコ科）、主要地域別市場規模（北米、アメリカ、欧州...

世界の前臨床オンコロジーCRO市場規模・現状・予測（2021年-2027年）

Global Preclinical Oncology CRO Market Size, Status and Forecast 2021-2027
QFJ1-4747 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、前臨床オンコロジーCROの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液がん、固形腫瘍、その他）、用途別市場規模（In Vitro、In Vivo）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の腫瘍小分子薬市場規模・現状・予測（2021年-2027年） Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Market Analysis and Insights: Global Oncology Small Molecule Drugs Market The global Oncology Small Molecule Drugs market …
世界の高分子注射薬市場規模・現状・予測（2021年-2027年） Large molecules (biologics), also called biopharmaceuticals, are a type of drugs. These are based on proteins which have a therapeutic effect. Market Analysis and Insights: Global Large Molecule Injectable Drugs Market The global Large Molecule Injectable Drugs market size is projected to reach US$ …
一般医薬品のグローバル市場2021 A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rathe…
吸入＆点鼻薬ジェネリック医薬品のグローバル市場2021 Inhalation & Nasal Spray is a kind of drug used to relieve sneezing, runny, stuffy, or itchy nose and itchy, watery eyes caused by hay fever or other allergies. Market competition is intense among the top 4. The sales of generic inhalers and nasal sprays is expected to increase even further after th…
世界のβ-ラクタム系薬剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Beta-Lactam Drugs Market The global Beta-Lactam Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…